Midwest SPR is committed to presenting the broadest possible range of high-quality work at the 2021 Scientific Meeting.
Historically, abstracts accepted for presentation are hypothesis-driven new work. Abstracts rarely accepted for presentation include open-label drug trials, single case reports, highly speculative accounts of clinical experience, and op-ed accounts of personal experience. Interim results from an ongoing clinical trial will not be accepted for presentation unless the study has been prematurely closed for efficacy, lack of efficacy, or issues of safety. The submission of multiple, similar abstracts from the same investigator(s) or laboratory are strongly discouraged.(coming soon) (coming soon)
General Submission Policies
- Character count is 2,600. A maximum of two images or tables may be uploaded with the abstract.
- Submitter does not need to be a member of Midwest SPR to submit an abstract for the Meeting.
- There is no limit on the number of abstracts submitted by each author, but the submission of multiple, similar abstracts from the same investigator(s) or laboratory is strongly discouraged.
- Abstracts submitted or presented to other societies or national meetings can be submitted for consideration.
- Research published in manuscript form prior to the submission of the abstract is not appropriate and should not be submitted. If data contained in the abstract is published after submission of the abstract, the Midwest SPR Program Office must be notified regardless of timing as soon as publication is recognized. At that time a member of the program committee will make a determination concerning presentation. Abstracts should not be submitted if there is knowledge and confirmation of an upcoming publication prior to the scientific meeting or submission deadline.
- Conflict of Interest/ Disclosure: Work submitted for presentation must include an acknowledgment of funding sources of commercial nature and/or consulting or holding of significant equity in a company that could be affected by the results of the study. Even if indicated elsewhere in the abstract, this must appear as the last sentence of the abstract and read “funded by…” and/or “equity in…” if pertinent.
- Any animal studies must conform with the “Guiding Principles in the Care and Use of Animals” of the American Physiological Society and any human experimentation has been conducted according to a protocol approved by the institutional committee on ethics of human investigation. And, if no such committee exists, it must conform with the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 14: 193, 1966).
- The submitting author verifies upon submission that all authors have agreed to the submission of the abstract.
- If the abstract is selected, the presentation must include the methods used for study and any other information relevant to research.
Abstract Selection Process
Abstracts of superior quality will be selected for presentation and will be graded based on quality of scientific merit/importance, research, design, data analysis and presentation. The submission of abstracts without data due to incomplete investigations or analyses will be evaluated only on the basis of the information provided.
Reviewer scores and comments are confidential and are not available to anyone (including authors) outside of the review process. The decision of the Program Committee to accept or decline an abstract is final. The decision on which format the abstract will be presented is also the decision of the Program Committee.
Notification of Receipt and Acceptance
Notification of receipt will be automatically emailed to the contact author upon submission of the abstract. Notification of abstract acceptance status will be emailed to the contact author listed on the abstract.
Note that the security firewall at some institutions may block communications from Midwest SPR. You can log into your Midwest SPR abstract account at any point to check for emails and invitations to present.
Award Consideration and Selection
Midwest SPR announces several awards during the meeting, based on abstracts accepted for presentation. There is no separate award submission process.
Publication of Abstracts
All abstracts (excluding tables and figures) accepted for presentation will be viewable in the mobile app. Full abstracts will be made available on the Midwest SPR website.
Attendance at the Midwest SPR Scientific Meeting
All presenters of accepted abstracts, either for platform or poster presentations, must register to attend the meeting. If the presenting author is unable to attend, another co-author named in the abstract may be designated to present, provided the change is communicated to Midwest SPR by Oct. 1, 2021.
ORAL PRESENTATION GUIDELINES
POSTER PRESENTATION GUIDELINES
Completion: Ask yourself:
- What do I want the viewer to remember?
- Is the message clear?
- Do important points stand out?
- Is there a balance between words and illustrations?
- Is the pathway through the poster clear?
- Is the poster understandable without oral explanation?